bf/NASDAQ:ALXO_icon.jpeg

NASDAQ:ALXO

ALX Oncology Holdings Inc.

  • Stock

USD

Last Close

1.18

06/11 21:20

Market Cap

352.20M

Beta: 1.66

Volume Today

268.71K

Avg: 271.68K

PE Ratio

−4.46

PFCF: −6.91

OverviewFinancialsAPI

    Description

    ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hodgkin's lymphoma, as well as a ran...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -3-2-12019-03-312020-11-122022-05-092023-11-132024-11-112025-08-06

    Revenue (Estimate*)

    1M2M3M4M5M2019-03-312020-11-122022-05-092023-11-132024-11-112025-08-06

    *Estimate based on analyst consensus